Literature DB >> 8329888

Dystrophin and dystrophin-related proteins: a review of protein and RNA studies.

D R Love1, B C Byth, J M Tinsley, D J Blake, K E Davies.   

Abstract

The analysis of dystrophin gene expression has led to the identification of multiple transcripts and varying isoforms. The data indicate that transcription of the dystrophin gene occurs from several promoters, which involves developmental and tissue-dependent regulation. These discoveries have complicated the interpretation of immunolocalization studies, although there is a strong correlation between the amount and size of dystrophin and the severity of the clinical phenotype. The importance of using protein-specific antibodies for dystrophin analysis has been underscored by the identification of a protein, designated utrophin, which exhibits significant sequence homology with dystrophin. This review addresses the recent studies of dystrophin and utrophin expression in an attempt to illustrate the transcriptional diversity of these large genes and the localization of their protein products within various tissues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8329888     DOI: 10.1016/0960-8966(93)90037-k

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  13 in total

1.  Effect of beta-dystroglycan processing on utrophin/Dp116 anchorage in normal and mdx mouse Schwann cell membrane.

Authors:  K Hnia; G Hugon; A Masmoudi; J Mercier; F Rivier; D Mornet
Journal:  Neuroscience       Date:  2006-06-02       Impact factor: 3.590

Review 2.  Progress in gene therapy of dystrophic heart disease.

Authors:  Y Lai; D Duan
Journal:  Gene Ther       Date:  2012-02-09       Impact factor: 5.250

3.  A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy.

Authors:  E A Burton; J M Tinsley; P J Holzfeind; N R Rodrigues; K E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy.

Authors:  K J Perkins; E A Burton; K E Davies
Journal:  Nucleic Acids Res       Date:  2001-12-01       Impact factor: 16.971

Review 5.  The dystrophin superfamily: variability and complexity.

Authors:  E Fabbrizio; F Pons; A Robert; G Hugon; A Bonet-Kerrache; D Mornet
Journal:  J Muscle Res Cell Motil       Date:  1994-12       Impact factor: 2.698

6.  In situ molecular association of dystrophin with actin revealed by sensitized emission immuno-resonance energy transfer.

Authors:  D D Root
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

Review 7.  The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy.

Authors:  B J Petrof
Journal:  Mol Cell Biochem       Date:  1998-02       Impact factor: 3.396

8.  Dystrophin and the cardiomyocyte membrane cytoskeleton in the healthy and failing heart.

Authors:  R R Kaprielian; N J Severs
Journal:  Heart Fail Rev       Date:  2000-10       Impact factor: 4.214

9.  Modulation by prednisolone of calcium handling in skeletal muscle cells.

Authors:  L Metzinger; A C Passaquin; W J Leijendekker; P Poindron; U T Rüegg
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

Review 10.  The roles of the dystrophin-associated glycoprotein complex at the synapse.

Authors:  Gonneke S K Pilgram; Saranyapin Potikanond; Richard A Baines; Lee G Fradkin; Jasprina N Noordermeer
Journal:  Mol Neurobiol       Date:  2009-11-09       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.